Form 8-K Chemours Co For: Nov 06

Go back to Form 8-K Chemours Co For: Nov 06

Chemours (CC) Tops Q3 EPS by 28c; adj.-EBITDA Rose ~59%

November 7, 2016 7:51 AM EST

Chemours (NYSE: CC) reported Q3 EPS of $0.61, $0.28 better than the analyst estimate of $0.33. Revenue for the quarter came in at $1.4 billion versus the consensus estimate of $1.4 billion.

Highlights:

Continued progress on all transformation plan objectives, including cost reductions, growth initiatives and portfolio rationalizationImproved cash from operating activities by ~$440 million year-to-dateRetired $315 million of long term debt through October 31, 2016Generated ~$685 million in gross proceeds from Chemical Solutions divestituresIncreased full-year Adjusted EBITDA... More